| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 09/23/2009 | EP1467989B1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection |
| 09/23/2009 | EP1461038B9 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 09/23/2009 | EP1237863B1 N-substituted perfluoroalkylated pyrrolidines, process for making them and process for the addition of rf-iodide to an olefin |
| 09/23/2009 | EP0946508B1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 09/23/2009 | CN101541747A Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
| 09/23/2009 | CN101538311A Alpha-amido acyl-ring imide peptoid metalloprotease inhibitor and application thereof |
| 09/23/2009 | CN101538256A 3, 4-diaryl furan-2, 5-diketone derivative and 3, 4-substitute-diaryl-1 H-pyrrole-2, 5-diketone derivative and application thereof |
| 09/23/2009 | CN101538243A Malononitrile compound and use thereof |
| 09/23/2009 | CN101538238A Polymorphs of atorvastatin tert.-butylester and use as intermediates for the preparation of atorvastatin |
| 09/23/2009 | CN101538237A Atorvastatin semi-calcium salt butanone co-crystallization substances, preparation and application thereof as HMG-CoA enzyme inhibitor |
| 09/23/2009 | CN101538236A Method for synthesizing lauroyl-prolyl amino acid methyl ester as novel transdermal enhancer and applications thereof |
| 09/22/2009 | US7592476 Process for producing enantiopure β-amino acid derivatives, and enantiopure β-amino acid derivatives |
| 09/22/2009 | US7592466 Ureas having antiangiogenic activity |
| 09/22/2009 | US7592465 Aqueous L-proline solution; desalting; environmentally friendly |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/22/2009 | US7592449 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 09/22/2009 | US7592365 4-{4-[3-(2-fluoro-5-trifluoromethylphenyl)ureido]phenyl}-1H-pyrrole-3-carboxamide; anticarcinogenic agents; FAK, KDR and Tie2 kinase inhibitors |
| 09/22/2009 | US7592364 Substituted gamma lactams as therapeutic agents |
| 09/22/2009 | US7592336 Hepatitis C virus inhibitors |
| 09/22/2009 | US7592074 Metal-containing dendrimers |
| 09/22/2009 | CA2454584C Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient |
| 09/22/2009 | CA2353727C Use of amtolmetin guacyl for the production of anti-inflammatory drugs for intestinal inflammations |
| 09/17/2009 | WO2009114307A1 Therapeutic compounds |
| 09/17/2009 | WO2009112678A2 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112677A2 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112529A1 Novel method for the production of sulphonylpyrroles as hdac inhibitors |
| 09/17/2009 | WO2009112275A1 Pesticidal condensed - ring aryl compounds |
| 09/17/2009 | US20090234138 Acyloxyalkyl carbamate prodrugs, methods |
| 09/17/2009 | US20090233972 Substituted heterocycles as anti-infectives |
| 09/17/2009 | US20090233969 Biaryl substituted nitrogen containing heterocycle inhibitors of lta4h for treating inflammation |
| 09/17/2009 | US20090233968 INHIBITORS OF THE ALPHA2BETA1/GPIa-IIA INTEGRIN |
| 09/17/2009 | US20090233274 Drug development target protein and target gene, and method of screening |
| 09/17/2009 | CA2719074A1 Novel method for the production of sulphonylpyrroles as hdac inhibitors |
| 09/17/2009 | CA2718199A1 Pesticidal condensed-ring aryl compounds |
| 09/17/2009 | CA2717632A1 Therapeutic compounds |
| 09/17/2009 | CA2712914A1 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 09/17/2009 | CA2712609A1 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 09/16/2009 | EP2100878A1 Novel method for the production of sulphonylpyrroles as HDAC inhibitors |
| 09/16/2009 | EP2099784A2 1,5-diphenyl-3-pyridinylamino-1,5-dihydrioyrrolidin-2-ones as cb1 receptor modulators |
| 09/16/2009 | EP2099748A1 Insecticidal benzamidines |
| 09/16/2009 | EP2099747A1 Radiolabelling via fluorination of aziridines |
| 09/16/2009 | EP1585515B1 Piperidine and pyrrolidine derivatives as antagonists of histamine h3 receptor |
| 09/16/2009 | EP1581488B1 Inhibitors of tace |
| 09/16/2009 | EP1562897B1 Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer s disease |
| 09/16/2009 | EP1487807B1 Cyano-pyrrolidines as DPP-IV inhibitors |
| 09/16/2009 | EP1083899B1 Derivatives of 1-deoxy-galactonojirimycin and their use in the treatment of lysosomal storage diseases by enhancing lysosomal alpha-galactosidase a |
| 09/16/2009 | CN101535251A Process for preparing 5-alkyl-7h-pyrrolo[2,3-d]pyrimidine-2-ols |
| 09/16/2009 | CN101535250A Pyrrole derivatives, preparation and use of the same in therapy |
| 09/16/2009 | CN101532996A Method for analyzing and separating levetiracetam by using HPLC method |
| 09/16/2009 | CN101531623A Method for preparing Doripenem and important intermediate thereof |
| 09/15/2009 | US7589216 Process for preparing N-hydroxyformamido-propyl pyrrolidin compounds and intermediates |
| 09/15/2009 | US7589207 Chemokine receptors; inhibition of HIV replication; acquired immune deficiency syndrome (AIDS); cis N-(4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylcyclohexyl)-1H-pyrazole-4-carboxamide |
| 09/15/2009 | US7589118 Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents; death receptor agonist; |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | US7589091 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 09/15/2009 | CA2571040C Preparation of pregabalin and related compounds |
| 09/15/2009 | CA2374471C Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same |
| 09/15/2009 | CA2218699C 1,3-propane diol derivatives as bioactive compounds |
| 09/11/2009 | WO2009111239A2 Pyrrolidine derivatives |
| 09/11/2009 | WO2009110002A1 Novel efflux pump inhibitors |
| 09/11/2009 | WO2009109539A2 Chemical compounds |
| 09/11/2009 | CA2717518A1 Pyrrolidine derivatives |
| 09/10/2009 | US20090227791 Active Esters of N-Substituted Piperazine Acetic Acids, Including Isotopically Enriched Versions Thereof |
| 09/10/2009 | US20090227653 Substituted gamma lactams as therapeutic agents |
| 09/10/2009 | US20090227635 Therapeutic compounds |
| 09/10/2009 | US20090227604 Vitamin d receptor modulators |
| 09/10/2009 | US20090227593 Cyclobutyl amine derivatives |
| 09/10/2009 | US20090227585 Substituted n-heterocycle derivatives and methods of their use |
| 09/10/2009 | US20090227567 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/10/2009 | US20090226510 Pharmaceutical compositions of atorvastatin |
| 09/09/2009 | EP2098508A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/09/2009 | EP2098507A1 Cyclic amine compound |
| 09/09/2009 | EP2098120A2 2-alkyl-cycloalk(en) yl-carboxamides |
| 09/09/2009 | EP2097405A2 Anti-viral compounds |
| 09/09/2009 | EP1678134B1 Preparation of 4,5-dialkyl-3-acyl-pyrrole-2-carboxylic acid derivatives by fischer-fink type synthesis and subsequent acylation |
| 09/09/2009 | EP1638963B1 N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors |
| 09/09/2009 | EP1587620B1 Hydrogenation catalysts |
| 09/09/2009 | EP1532109B1 Pyrrolidine derivatives as oxytocin antagonists |
| 09/09/2009 | CN101528687A Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same |
| 09/09/2009 | CN101528686A Amide compound or salt thereof, and biofilm formation inhibitor, biofilm remover and bactericide each using the amide compound or salt thereof |
| 09/09/2009 | CN101528685A New benzamide derivatives as brad ykinin antagonists |
| 09/09/2009 | CN101528684A Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 09/09/2009 | CN100537535C Compound of containing cation radical of L - proline, preparation method, and application |
| 09/09/2009 | CN100537534C Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 09/09/2009 | CN100537527C Aryl and biaryl compounds having MCH modulatory activity |
| 09/08/2009 | US7585976 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 09/08/2009 | US7585886 Pyrrolidine derivative or salt thereof |
| 09/08/2009 | US7585885 Beta -secretase (BACE); Alzheimer's disease; 2-(R)-[2-(S)-Amino-3-(3,5-difluorophenyl)-1-(S)-hydroxypropyl]-pyrrolidine-1-carboxylic acid tert-butyl ester |
| 09/08/2009 | US7585882 Phosphodiesterase 4 inhibitors |
| 09/08/2009 | CA2487540C Process for the preparation of free-flowing, pulverized atorvastatin adsorbates |
| 09/08/2009 | CA2334010C Novel peroxidase substrates and their use in catalyzed reporter deposition |
| 09/08/2009 | CA2290745C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 09/03/2009 | WO2009106894A1 Novel crystalline forms |
| 09/03/2009 | WO2009082437A3 Selective androgen receptor modulators (sarms) and uses thereof |
| 09/03/2009 | US20090221667 Process for Annealing Amorphous Atorvastatin |
| 09/03/2009 | US20090221546 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
| 09/03/2009 | US20090220407 Preparation and functionalization of carbon nano-onions |
| 09/03/2009 | CA2715726A1 Novel crystalline forms |